D. E. Shaw & Co., Inc. Insulet Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $4.52 Million - $5.77 Million	27,600 Added 2123.08%	28,900 $4.95 Million
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $332,202 - $575,692	-2,600 Reduced 66.67%	1,300 $282,000
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $603,213 - $1.13 Million	3,900 New	3,900 $622,000
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $3.9 Million - $5.26 Million	-17,300 Reduced 63.37%	10,000 $2.75 Million
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $620,763 - $876,447	-3,900 Reduced 12.5%	27,300 $5.3 Million
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $1.66 Million - $2.77 Million	12,800 Added 69.57%	31,200 $5.17 Million
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $202,734 - $260,400	1,400 Added 8.24%	18,400 $3.15 Million
Q2 2018 Aug 14, 2018	BUY	$83.27 - $101.93 $1.42 Million - $1.73 Million	17,000 New	17,000 $1.46 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.